N
Neurocare
Health Tech & Medtech · Munich, Germany · Founded 2015
Neurocare group develops personalized digital therapies to improve patients' mental health MoreLess
Neurocare Group is a global company that provides personalized mental health care and performance enhancement services. The company operates a network of clinics and offers services to both individuals and clinicians.
Neurocare's approach is centered around integrating technology and science into mental health treatment. They utilize a variety of methods, including psychotherapy, and neuromodulation techniques like the FDA-approved repetitive Transcranial Magnetic Stimulation (rTMS) and neurofeedback, to create personalized treatment plans. These plans are based on a comprehensive assessment of each individual's unique brain activity and psychological profile. The company treats a range of conditions, including depression, obsessive-compulsive disorder (OCD), ADHD, and sleep problems.
For clinicians and researchers, Neurocare provides the necessary hardware and software for therapy and research, along with training and support. This enables other professionals to adopt Neurocare's integrated approach in their own practices. It operates clinics and offers its digital therapy platform across multiple countries including the United States, Australia, the Netherlands, the UK & Ireland, and the Middle East.
Keywords: mental healthcare, neuromodulation, rTMS, neurofeedback, psychotherapy, depression, OCD, ADHD, sleep disorders, personalized medicine
Company overview
Neurocare company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2015
- Headquarters
- Munich, Germany
- Employees
- 159
- Open positions
- 7
- Dealroom signal
- 77.3
- Investment activity
- 2 companies · latest Jul 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Neurocare funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Feb 2025 | $21M | $85M | TVM Capital Healthcare · Impact Expansion | ↗ |
| GROWTH EQUITY VC✓Equity / VC | Apr 2024 | $17M | — | TVM Capital Healthcare | ↗ |
| ACQUISITION✓Exit | May 2015 | $0 | — | Passion Innovation Group | — |
| SEED✓Equity / VC | Jan 2006 | — | — | Undisclosed | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | Profit | Margin |
|---|---|---|---|---|
| 2026 | $2.8M | 0% | $100K | 3.6% |
| 2025 | $2.8M | 0% | $100K | 3.6% |
| 2024 | $2.8M | 0% | $100K | 3.6% |
| 2023 | $2.8M | 0% | ||
| 2022 | $2.8M | 0% | ||
| 2021 | $2.8M | 0% | ||
| 2020 | $2.8M | — |
Growth signals
Neurocare website traffic
Latest recorded traffic for Neurocare is 37K monthly website visits, up 12.1% over the last three months. Neurocare's team grew 3.9% over the past year.
Hiring
Open positions at Neurocare
Current openings linked to this company in Dealroom.
Comparisons
Neurocare compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Neurocare investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
MeJa PsychologieGroningen, NetherlandsPsychological care specializing in pregnancy and parenthood
→
Smart tmsUnited KingdomTranscranial Magnetic Stimulation Treatment (TMS) - Smart TMS
$4.1Mvaluation
Mid-Ohio Behavioral HealthNew Albany, United StatesComprehensive outpatient mental and behavioral health services
→
Talent graph
Neurocare's talent
Source: Dealroom Talent Intelligence.
Investors
7 investors on Neurocare's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Neurocare has talent and traffic
team presence
In the news
Latest news about Neurocare
Recent press, funding announcements, and product moves mentioning Neurocare — open to read from the original sources.
Market sentiment
What the market is saying about Neurocare
An AI-synthesized read of the highest-engagement posts about Neurocare on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Neurocare’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.